Literature DB >> 29473509

Bis-coumarin Derivatives and Their Biological Activities.

Qing-Cheng Ren1, Chuan Gao1, Zhi Xu1, Lian-Shun Feng1, Ming-Liang Liu2,3, Xiang Wu1, Feng Zhao1.   

Abstract

Bis-coumarins have caused great interests in the recent years. These compounds exhibit diverse biological activities which are ascribed to their ability to exert noncovalent interactions with the various active sites in organisms. Some of them such as dicoumarolum and dicoumarol were approved for therapeutic purposes in clinical practice. Encouraged by the above facts, numerous biscoumarin derivatives have been synthesized and screened for their biological activities, and many of them showed promising potency. This review is focused on the biological potential of bis-coumarin derivatives with particular mention of those exhibiting antibacterial, anticoagulant, antiinflammatory, antiviral, anti-parasite and antitumor activities, and their structure-activity relationships are also discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Bis-coumarin; anti-bacterial; antitumor; antiviral; hybrid compounds; structure-activity relationships.

Mesh:

Substances:

Year:  2018        PMID: 29473509     DOI: 10.2174/1568026618666180221114515

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  7 in total

Review 1.  Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.

Authors:  Mamdouh F A Mohamed; Gamal El-Din A Abuo-Rahma
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

Review 2.  Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine.

Authors:  Mohammad Bagher Majnooni; Sajad Fakhri; Antonella Smeriglio; Domenico Trombetta; Courtney R Croley; Piyali Bhattacharyya; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Anupam Bishayee
Journal:  Molecules       Date:  2019-11-24       Impact factor: 4.411

Review 3.  Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease.

Authors:  Zhoupeng Li; Dehui Kong; Yongsheng Liu; Mingkai Li
Journal:  Genes Dis       Date:  2021-04-20

Review 4.  Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms.

Authors:  Javad Sharifi-Rad; Natália Cruz-Martins; Pía López-Jornet; Eduardo Pons-Fuster Lopez; Nidaa Harun; Balakyz Yeskaliyeva; Ahmet Beyatli; Oksana Sytar; Shabnum Shaheen; Farukh Sharopov; Yasaman Taheri; Anca Oana Docea; Daniela Calina; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-08-23       Impact factor: 6.543

5.  Design, Synthesis, Spectroscopic Characterisation and In Vitro Cytostatic Evaluation of Novel Bis(coumarin-1,2,3-triazolyl)benzenes and Hybrid Coumarin-1,2,3-triazolyl-aryl Derivatives.

Authors:  Kristina Pršir; Ema Horak; Marijeta Kralj; Lidija Uzelac; Sandra Liekens; Ivana Murković Steinberg; Svjetlana Krištafor
Journal:  Molecules       Date:  2022-01-19       Impact factor: 4.411

6.  A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis.

Authors:  Asma Farjallah; Laurent R Chiarelli; Martin Forbak; Giulia Degiacomi; Mathieu Danel; Fernanda Goncalves; Chantal Carayon; Cendrine Seguin; Marco Fumagalli; Monika Záhorszká; Elodie Vega; Souhir Abid; Anna Grzegorzewicz; Mary Jackson; Antonio Peixoto; Jana Korduláková; Maria Rosalia Pasca; Christian Lherbet; Stefan Chassaing
Journal:  ACS Infect Dis       Date:  2021-02-22       Impact factor: 5.084

7.  Integrated metabolomics and transcriptomics study of traditional herb Astragalus membranaceus Bge. var. mongolicus (Bge.) Hsiao reveals global metabolic profile and novel phytochemical ingredients.

Authors:  Xueting Wu; Xuetong Li; Wei Wang; Yuanhong Shan; Cuiting Wang; Mulan Zhu; Qiong La; Yang Zhong; Ye Xu; Peng Nan; Xuan Li
Journal:  BMC Genomics       Date:  2020-11-18       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.